Clinical Trials · NCT07893457
Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 30
- Start date
- Oct 2026
- Locations
- 1 site, United States
- Primary endpoint
- Total Esophageal Acid Exposure Time During 96-Hour Wireless pH Monitoring